Mounting data suggests that amino acid sequence therapies represent a exciting revolutionary area for malignant treatment. Unlike conventional drug therapy, these approaches can be designed to specifically target tumor tissue while minimizing impact to non-cancerous cells. This specificity holds the potential for improved efficacy and less side ef